Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease

Tau hyperphosphorylation is a typical pathological change in Alzheimer's disease (AD) and is involved in the early onset and progression of AD. Epigenetic modification refers to heritable alterations in gene expression that are not caused by direct changes in the DNA sequence of the gene. Epige...

Description complète

Détails bibliographiques
Publié dans:Neural plasticity. - 1998. - 2019(2019) vom: 15., Seite 6856327
Auteur principal: Yu, Chao-Chao (Auteur)
Autres auteurs: Jiang, Tao, Yang, Ao-Fei, Du, Yan-Jun, Wu, Miao, Kong, Li-Hong
Format: Article en ligne
Langue:English
Publié: 2019
Accès à la collection:Neural plasticity
Sujets:Journal Article Research Support, Non-U.S. Gov't Review MAPT protein, human RNA, Untranslated tau Proteins
Description
Résumé:Tau hyperphosphorylation is a typical pathological change in Alzheimer's disease (AD) and is involved in the early onset and progression of AD. Epigenetic modification refers to heritable alterations in gene expression that are not caused by direct changes in the DNA sequence of the gene. Epigenetic modifications, such as noncoding RNA regulation, DNA methylation, and histone modification, can directly or indirectly affect the regulation of tau phosphorylation, thereby participating in AD development and progression. This review summarizes the current research progress on the mechanisms of epigenetic modification associated with tau phosphorylation
Description:Date Completed 10.12.2019
Date Revised 09.03.2020
published: Electronic-eCollection
Citation Status MEDLINE
ISSN:1687-5443
DOI:10.1155/2019/6856327